Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
942.55
3.35 (0.36%) Cadila Healthcare board to consider unaudited financial results
Date: 15-10-2012Cadila Healthcare has informed that a meeting of the board of the directors of the company will be held on November 07, 2012, to consider unaudited financial results for the quarter/half-year ended on September 30, 2012 (Q2).
The above information is a part of company's filings submitted to BSE.